麻豆传媒色情片

News

Spider-like proteins spin defenses to control immunity

Inayah Entzminger
Oct. 17, 2025

Human blood contains spider-shaped proteins that regulate the innate immune response. When antibodies attach to a pathogen, complement protein C1 binds to them and triggers a cascade of protein cleavages that amplify the immune signal. C1 activation initiates successive complement protein cleavages and amplifies the signal to the immune system.

To prevent harmful inflammation, the body relies on regulators to shut down the cascade. Researchers from Utrecht University, including Tereza Kadav谩 and Albert Heck, Leiden University Medical Center and the University of Applied Sciences in Austria revealed how the spider-like complement regulator C4b-binding protein, or C4BP, binds its immune targets. They reported their in 麻豆传媒色情片 & Cellular Proteomics.

Albert Heck
This 3D visualization of C4BP was created by Hecklab in collaboration with Sensu.health. C4BP uses its eight “legs” to catch proteins related to inflammation, stopping further immune response.

C4b plays a role in the classical and lectin complement pathways, which culminate in the formation of the membrane attack complex, or MAC. The MAC is a cylindrical protein complex that forms pores in the pathogenic bacterial cell membrane, which leads to cell death.

C4BP is an essential cofactor for serine protease factor I, or FI, which cleaves C4b and generates inactive C4b, or iC4b. This blocks activation of the rest of the complement cascade and prevents MAC formation.

Previous studies have found that most human serum C4BP is bound to serum amyloid P component, or SAP. When not bound to C4BP, SAP can bind to viruses, bacteria and malaria parasites and induce phagocytosis of the bound pathogens.

While it is known that C4BP, C4b and SAP play a role in complement inhibition, the team wanted to better understand the C4BP-C4b and C4BP-SAP complex structures. They used mass photometry, cross-linking mass spectrometry and high-speed atomic force microscopy to image the unbound proteins and the complexes they form. Mass photometry is a technique that uses a laser to detect single molecules in solution as they adsorb onto a glass surface.

They found that the N-terminal domain of a C4BPα chain, or one leg of the spider-like C4BP, binds to C4b in a 1:1 ratio. This allows the C4BP higher-order structure, or HOS, to bind multiple molecules of C4b.

When bound with SAP, researchers found a strong preference for 1:1 C4BP:SAP ratios. SAP did not bind to a single C4BPα construct, only the intact full C4BP HOS. AFM Microscopy revealed C4BPα chains encircling the SAP protein, with the C4BP core perched on top, like a spider grasping a fly.

These findings support previous research on the regulatory mechanisms of C4BP-SAP complex formation. C4b and SAP can both bind to C4BP, but SAP likely limits the flexibility of C4BPα chains, reducing its ability to inhibit the complement system.

SAP is a therapeutic target for treating fibrosing diseases associated with chronic inflammation. Previous studies proposed that human serum C4BP is mostly bound to SAP when the immune complement system is not triggered. This study determined the binding stoichiometry between C4BP and SAP as well as the structural configuration, which could aid drug development targeting SAP.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Inayah Entzminger

Inayah Entzminger is an ASBMB Today careers columnist.

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

A biological camera: How AI is transforming retinal imaging
Feature

A biological camera: How AI is transforming retinal imaging

Oct. 15, 2025

AI is helping clinicians see a more detailed view into the eye, allowing them to detect diabetic retinopathy earlier and expand access through tele-ophthalmology. These advances could help millions see a clearer future.

AI in the lab: The power of smarter questions
Essay

AI in the lab: The power of smarter questions

Oct. 14, 2025

An assistant professor discusses AI's evolution from a buzzword to a trusted research partner. It helps streamline reviews, troubleshoot code, save time and spark ideas, but its success relies on combining AI with expertise and critical thinking.

Training AI to uncover novel antimicrobials
Feature

Training AI to uncover novel antimicrobials

Oct. 9, 2025

Antibiotic resistance kills millions, but César de la Fuente鈥檚 lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.

AI-designed biomarker improves malaria diagnostics
Journal News

AI-designed biomarker improves malaria diagnostics

Oct. 8, 2025

Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.

Matrix metalloproteinase inhibitor reduces cancer invasion
Journal News

Matrix metalloproteinase inhibitor reduces cancer invasion

Oct. 8, 2025

Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.

Antibiotic sensor directly binds drug in resistant bacteria
Journal News

Antibiotic sensor directly binds drug in resistant bacteria

Oct. 8, 2025

Researchers at Drexel University uncover how the vancomycin-resistant bacterial sensor binds to the antibiotic, offering insights to guide inhibitor design that restores antibiotic effectiveness against hospital-acquired infections.